Oruka Therapeutics, Inc. ORKA Paid-in-kind interest capitalized
Paid-in-kind interest capitalized at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaidInKindInterest.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s paid-in-kind interest capitalized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s paid-in-kind interest capitalized?
- Oruka Therapeutics, Inc. (ORKA) reported paid-in-kind interest capitalized of $1.47M in Q4 2024.
- What does paid-in-kind interest capitalized mean?
- Captures interest expense that is settled by issuing additional debt or equity instruments rather than through cash payments. This metric is critical for assessing the company's true leverage and cash flow obligations. It highlights instances where interest costs are deferred, potentially increasing the total debt burden over time.